SCHEMBL18673

SCHEMBL18673

O=C(CCCCC(=O)OCc1ccccc1)OCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.68
MAPK1 P28482 2/20 0.68
L3MBTL1 Q9Y468 2/20 0.68
TDP1 Q9NUW8 3/20 0.57
KMT2A Q03164 2/20 0.57
SLC6A2 P23975 1/20 0.57
SLC6A3 Q01959 1/20 0.57
LMNA P02545 2/20 0.54
EPHX2 P34913 1/20 0.53
HTT P42858 1/20 0.53
HCAR2 Q8TDS4 1/20 0.52
NOTUM Q6P988 1/20 0.50
MEN1 O00255 1/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
CDC25B P30305 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10621313 0.98 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL28600680 0.98 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL20624816 0.98 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL4941879 0.98 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL10621326 0.98 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL28434793 0.98 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL118235 0.98 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL2926392 0.98 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL27453585 0.98 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL27638136 0.98 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 300 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240210727-A1 OPHTHALMIC ARTICLES MADE FROM CELLULOSE ESTER COMPOSITIONS HAVING HIGH TOUGHNESS AND DIMENSIONAL STABILITY EASTMAN CHEMICAL COMPANY (US) 2024-06-27 US claimed
EP-4320187-A1 OPHTHALMIC ARTICLES MADE FROM CELLULOSE ESTER COMPOSITIONS HAVING HIGH TOUGHNESS AND DIMENSIONAL STABILITY Eastman Chemical Company (US) 2024-02-14 EP claimed
CN-117178017-A Ophthalmic articles having high toughness and dimensional stability made from cellulose ester compositions 伊士曼化工公司 2023-12-05 CN claimed
WO-2022216473-A1 OPHTHALMIC ARTICLES MADE FROM CELLULOSE ESTER COMPOSITIONS HAVING HIGH TOUGHNESS AND DIMENSIONAL STABILITY EASTMAN CHEMICAL COMPANY (US) 2022-10-13 WO claimed
CN-110662746-B Compounds as orally administered prodrugs of beta-lactamase inhibitors, pharmaceutical compositions thereof and use for treating bacterial infections 阿里萨制药有限公司 2022-08-19 CN claimed
CN-106083570-B A kind of preparation method of (2R, 5R) 2,5 dibenzyl adipic acid 宁波九胜创新医药科技有限公司 2018-04-10 CN claimed
CN-106083570-A A kind of preparation method of (2R, 5R) 2,5 dibenzyl adipic acid 宁波九胜创新医药科技有限公司 2016-11-09 CN claimed
CN-106103619-A Thermally sensitive polymeric base material, Its Preparation Method And Use through adhesive coating 诺瓦美特胶粘技术公司 2016-11-09 CN claimed
EP-2039718-B1 Quickly coagulating softener preparations LANXESS DEUTSCHLAND GMBH (DE) 2016-08-17 EP claimed
US-8063125-B2 Phthalate-free; aryl alkylsulfonate (phenyl C12-C20-alkylsulfonate) and diol dibenzoate or dibenzyl dicarboxylate such as dibenzyl adipate; plasticizer in plastics LANXESS DEUTSCHLAND GMBH (DE) 2011-11-22 US claimed
US-20090197998-A1 FAST-GELLING PLASTICIZER PREPARATIONS LANXESS DEUTSCHLAND GMBH (DE) 2009-08-06 US claimed
EP-0287416-B1 Process for the manufacture of masticated polyvinyl butyral for the bonding of a supporting bed to a screen, and products obtained SAINT GOBAIN VITRAGE (FR) 1994-07-27 EP claimed
US-5187217-A Reacting butyral with a Polyvinyl Alcohol having 98% hydrolysis and a viscosity of at least 50 cP to obtain hydroxylation of 23 to 25% using an acid catalyst, plasticizer and emulsifier SAINT-GOBAIN VITRAGE (FR) 1993-02-16 US claimed
US-4492782-A POLYCAPROLACTONE BIP CHEMICALS LIMITED (GB) 1985-01-08 US claimed
US-4071507-A POLYMERIZATION STAMICARBON, N.V. (NL) 1978-01-31 US claimed
US-3950294-A AQUEOUS COATING COMPOSITIONS OF DISPERSIONS OF THERMOPLASTIC ADDITION POLYMERS WITH LOW MOLECULAR WEIGHT PLASTICIZERS CONNELLY WILLIAM 1976-04-13 US claimed
US-20260069734-A1 FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS ARYLESSENCE INC (US) 2026-03-12 US disclosed
US-20260047987-A1 BIODEGRADABLE SPHERICAL PARTICLES AND PRODUCTION METHOD THEREFOR DAICEL CORPORATION (JP) 2026-02-19 US disclosed
US-3950294-A AQUEOUS COATING COMPOSITIONS OF DISPERSIONS OF THERMOPLASTIC ADDITION POLYMERS WITH LOW MOLECULAR WEIGHT PLASTICIZERS CONNELLY WILLIAM 1976-04-13 US disclosed
US-3862225-A D-RING SUBSTITUTED TETRACYCLINES PFIZER 1975-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260047987-A1 BIODEGRADABLE SPHERICAL PARTICLES AND PRODUCTION METHOD THEREFOR PGA5, CD68, SBDS ALDH1A1 1216/4885MAPK1 4278/4885L3MBTL1 4192/4885
US-20260069734-A1 FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS FFAR1, FFAR2, FFAR3 ALDH1A1 697/4885MAPK1 3240/4885L3MBTL1 4774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.